Related Experiment Video
Updated: Jun 26, 2026
07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Mutactimycin E, a new anthracycline antibiotic with gram-positive activity
D Craig Hopp1, John Rabenstein, Joshua Rhea
1AMRI, Bothell Research Center, Bothell, WA 98011, USA.
The Journal of Antibiotics
|January 27, 2009
Summary
Researchers discovered a new natural compound, mutactimycin E, from the AMRI library. This compound shows moderate activity against gram-positive bacteria, offering a potential new weapon against antibiotic resistance.
Area of Science:
- Natural Product Chemistry
- Microbiology
- Drug Discovery
Background:
- Antibiotic resistance is a growing global health crisis.
- Natural products have historically been a rich source of antibacterial agents.
- The need for novel therapeutics against multidrug-resistant bacteria is urgent.
Purpose of the Study:
- To identify novel antibacterial compounds from natural sources.
- To investigate the AMRI natural product library for activity against multidrug-resistant Staphylococcus aureus (MDRSA).
- To isolate and characterize new metabolites with potential therapeutic applications.
Main Methods:
- Screening of the AMRI natural product library against MDRSA.
- Cytotoxicity assays using HepG2 cells to determine in vitro therapeutic index (in vitro TI).
- Fractionation and dereplication of active, non-cytotoxic compounds.
- Structure elucidation and biological activity assessment of the new compound.
Main Results:
- A new anthracycline, mutactimycin E (1), was discovered.
- Mutactimycin E demonstrated moderate activity against several gram-positive organisms.
- The study successfully isolated and elucidated the structure of a novel natural product.
Conclusions:
- Mutactimycin E represents a promising new lead compound for antibacterial drug development.
- Natural product discovery remains a vital strategy for combating antibiotic resistance.
- Further research into mutactimycin E's mechanism of action and efficacy is warranted.
Related Concept Videos
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...